In solid-organ transplant recipients (OTRs) diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA ...

T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous ...

To determine whether sirolimus (SIR) and cyclosporine (CSP) combined with post-transplantation cyclophosphamide (PTCy), after nonmyeloablative or reduced-intensity conditioning unrelated donor ...

January 18, 2007 -- Primary kidney-transplant recipients maintained on sirolimus ( Rapamune, Wyeth) and cyclosporine ( Neoral, Novartis) immunosuppression after a 5-day induction with antithymocyte ...

The two medications can be administered concomitantly if various factors are taken into account. CHICAGO—Clinicians can safely use sirolimus and voriconazole concurrently if certain steps are followed ...

For patients with leukemias, certain types of anemias, or specific autoimmune disorders, hematopoietic stem cell transplantation is a life-saving procedure. This treatment involves suppressing a ...

After transplantation, patients are placed on immunosuppression to prevent acute and chronic rejection of the transplanted organ. The immunosuppressive agents used to treat acute rejection and nursing ...

A drug used to prevent organ rejection in kidney transplant patients is being touted for potentially slowing down aging. The immune-suppressing medication rapamycin, also known as sirolimus, is being ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. During the study period, 11.4% of solid organ transplant ...

Please provide your email address to receive an email when new articles are posted on . Four of six patients who used sirolimus had positive responses and discontinued systemic corticosteroids. Three ...